"O Hospital Dia do Pulmão atua em Blumenau desde 1982, com prestação de serviços voltados ao diagnóstico e tratamento de doenças respiratórias. Pneumologia Adulto | Pneumologia Pediátrica | Fisioterapia Respiratória | Alergologia | Otorrinolaringologia | Cirurgia torácica Pronto Atendimento | Exames e tratamentos | Sala de Vacinas - reconhecida e acreditada pela Sociedade Brasileira de Imunizações (SBIm) Responsável Técnico - Dr. Mauro Sérgio Kreibich CRM 2367 | RQE 881"

During the past decade, Hospital Dia do Pulmão conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Dia do Pulmão" #1 sponsor was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials, followed by "Reata Pharmaceuticals, Inc." with 2 trials sponsored, "Corvus Pharmaceuticals, Inc." with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "FibroGen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Dia do Pulmão" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Dia do Pulmão" are "Pulmonary Arterial Hypertension" (3 trials), "COVID-19" (1 trials), "Connective Tissue Disease-Associated Pulmonary Arterial Hypertension" (1 trials), "Coronavirus Disease 2019" (1 trials) and "Covid-19" (1 trials). Many other conditions were trialed in "Hospital Dia do Pulmão" in a lesser frequency.

Most popular intervention types in "Hospital Dia do Pulmão" are "Drug" (8 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Sotatercept" (3 trials), "Background PAH Therapy" (1 trials), "Bardoxolone methyl" (1 trials) and "Bardoxolone methyl capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Dia do Pulmão" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Dia do Pulmão". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Dia do Pulmão, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Dia do Pulmão, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".